内镜十二指肠空肠套管在治疗肥胖合并2型糖尿病中的应用
Application of Endoscopic Duodenal-Jejunal Bypass Sleeve in the Treatment of Obesity Combined with Type 2 Diabetes Mellitus
DOI: 10.12677/ACM.2024.143700, PDF,   
作者: 韩额尔敦:内蒙古医科大学第一临床医学院,内蒙古 呼和浩特
关键词: 内镜胃旁路术减重手术2型糖尿病Endoscopy Gastric Bypass Surgery Bariatric Surgery Type 2 Diabetes
摘要: 肥胖症(Obesity)已成为全球最常见的流行病之一,其发病率仍然在持续增加。肥胖合并代谢性疾病已严重威胁了人类健康,尤其是合并2型糖尿病(T2DM)。目前,手术已成为治疗肥胖合并2型糖尿病的最有效的手段。随着减重代谢手术的快速发展,内镜下十二指肠–空肠套管置入术(EDJBS)被给予广泛关注,其非侵入性和可逆性等特点使其成为未来减重代谢手术的重要方向。因为研究较少和不良反应发生率较高的原因,EDJBS尚未在国内广泛使用。相信随着手术的不断推广、外科医生的技能不断提升、装置材料的不断改善、改善体重和代谢的机制不断挖掘,EDJBS也将逐步在国内得到开展,从而对减重代谢外科的发展和T2DM的治愈产生深远影响。该文针对EDJBS术式的发展历史、作用机制和不良反应等方面进行综述。
Abstract: Obesity has become one of the most common epidemics in the world, and its incidence is still in-creasing. Obesity combined with metabolic diseases has seriously threatened human health, espe-cially type 2 diabetes mellitus (T2DM). At present, surgery has become the most effective means of treating obesity with type 2 diabetes. With the rapid development of bariatric and metabolic sur-gery, endoscopic duodenal-jejunal bypass sleeve (EDJBS) has received extensive attention, and its non-invasive and reversible characteristics make it an important direction for bariatric and meta-bolic surgery in the future. EDJBS has not been widely used in China because of few studies and high incidence of adverse reactions. It is believed that with the continuous promotion of surgery, the continuous improvement of surgeons’ skills, the continuous improvement of device materials and the continuous exploration of mechanisms for improving body weight and metabolism, EDJBS will also be gradually carried out in China, which will have a profound impact on the development of bariatric and metabolic surgery and the cure of diabetes. This article reviews the development his-tory, mechanism of action and adverse reactions of EDJBA.
文章引用:韩额尔敦. 内镜十二指肠空肠套管在治疗肥胖合并2型糖尿病中的应用[J]. 临床医学进展, 2024, 14(3): 298-304. https://doi.org/10.12677/ACM.2024.143700

参考文献

[1] Wang, L., Zhou, B., Zhao, Z., et al. (2021) Body-Mass Index and Obesity in Urban and Rural China: Findings from Consecutive Nationally Representative Surveys during 2004-18. The Lancet, 398, 53-63. [Google Scholar] [CrossRef
[2] Blüher, M. (2019) Obesity: Global Epidemiology and Path-ogenesis. Nature Reviews Endocrinology, 15, 288-298. [Google Scholar] [CrossRef] [PubMed]
[3] Pories, W.J., Swanson, M.S., MacDonald, K.G., et al. (1995) Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset Diabetes Mellitus. Annals of Surgery, 222, 339-502. [Google Scholar] [CrossRef] [PubMed]
[4] 杨华, 陈缘, 董志勇, 等. 中国肥胖代谢外科数据库: 2020年度报告[J]. 中华肥胖与代谢病电子杂志, 2021, 7(1): 1-7.
[5] Laferrère, B. and Pattou, F. (2018) Weight-Independent Mechanisms of Glucose Control after Roux-En-Y Gastric Bypass. Frontiers in Endocrinology, 9, Article 530. [Google Scholar] [CrossRef] [PubMed]
[6] Tsesmeli, N. and Coumaros, D. (2009) Review of En-doscopic Devices for Weight Reduction: Old and New Balloons and Implantable Prostheses. Endoscopy, 41, 1082-1089. [Google Scholar] [CrossRef] [PubMed]
[7] Tarnoff, M., Rodriguez, L., Escalona, A., et al. (2009) Open Label, Prospective, Randomized Controlled Trial of an Endoscopic Duodenal-Jejunal Bypass Sleeve versus Low Calorie Diet for Pre-Operative Weight Loss in Bariatric Surgery. Surgical Endoscopy, 23, 650-656. [Google Scholar] [CrossRef] [PubMed]
[8] 中华医学会外科学分会甲状腺及代谢外科学组, 中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 中国肥胖及2型糖尿病外科治疗指南(2019版) [J]. 中国实用外科杂志, 2019, 39(4): 301-306.
[9] Riedel, N., Laubner, K., Lautenbach, A., et al. (2018) Longitudinal Evaluation of Efficacy, Safety and Nutritional Status during One-Year Treatment with the Duodenal-Jejunal Bypass Liner. Surgery for Obesity and Related Diseases, 14, 769-779. [Google Scholar] [CrossRef] [PubMed]
[10] Hutch, C.R. and Sandoval, D. (2017) The Role of GLP-1 in the Metabolic Success of Bariatric Surgery. Endocrinology, 158, 4139-4151. [Google Scholar] [CrossRef] [PubMed]
[11] Moffett, R.C., Docherty, N.G. and Le Roux, C.W. (2021) The Altered Enteroendocrine Reportoire Following Roux-En-Y-Gastric Bypass as an Effector of Weight Loss and Improved Glycae-mic Control. Appetite, 156, Article ID: 104807. [Google Scholar] [CrossRef] [PubMed]
[12] Jiao, Z.T. and Luo, Q. (2022) Molecular Mechanisms and Health Benefits of Ghrelin: A Narrative Review. Nutrients, 14, Article 4191. [Google Scholar] [CrossRef] [PubMed]
[13] Tuero, C., Valenti, V., Rotellar, F., et al. (2020) Revisiting the Ghrelin Changes Following Bariatric and Metabolic Surgery. Obesity Surgery, 30, 2763-2780. [Google Scholar] [CrossRef] [PubMed]
[14] Nauck, M.A. and Meier, J.J. (2018) Incretin Hormones: Their Role in Health and Disease. Diabetes, Obesity and Metabolism, 20, 5-21. [Google Scholar] [CrossRef] [PubMed]
[15] Dimitriadis, G.K., Randeva, M.S. and Miras, A.D. (2017) Potential Hor-mone Mechanisms of Bariatric Surgery. Current Obesity Reports, 6, 253-265. [Google Scholar] [CrossRef] [PubMed]
[16] Guida, C., Stephen, S.D., Watson, M., et al. (2019) PYY Plays a Key Role in the Resolution of Diabetes Following Bariatric Surgery in Humans. eBioMedicine, 40, 67-76. [Google Scholar] [CrossRef] [PubMed]
[17] Jirapinyo, P., Haas, A.V. and Thompson, C.C. (2018) Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients with Type 2 Diabetes with Obesity: A Me-ta-Analysis with Secondary Analysis on Weight Loss and Hormonal Changes. Diabetes Care, 41, 1106-1115. [Google Scholar] [CrossRef] [PubMed]
[18] Ruban, A., Uthayakumar, A., Ashrafian, H., et al. (2018) Endoscopic In-terventions in the Treatment of Obesity and Diabetes. Digestive Diseases and Sciences, 63, 1694-1705. [Google Scholar] [CrossRef] [PubMed]
[19] Rubino, F., Forgione, A., Cummings, D.E., et al. (2006) The Mechanism of Diabetes Control after Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 Diabetes. Annals of Surgery, 244, 741-749. [Google Scholar] [CrossRef] [PubMed]
[20] Ley, R.E., Turnbaugh, P.J., Klein, S., et al. (2006) Mi-crobial Ecology: Human Gut Microbes Associated with Obesity. Nature, 444, 1022-1023. [Google Scholar] [CrossRef] [PubMed]
[21] Magouliotis, D.E., Tasiopoulou, V.S., Sioka, E., et al. (2017) Impact of Bariatric Surgery on Metabolic and Gut Microbiota Profile: A Systematic Review and Meta-Analysis. Obesity Surgery, 27, 1345-1357. [Google Scholar] [CrossRef] [PubMed]
[22] Paranjape, S.A., Chan, O., Zhu, W., et al. (2013) Improvement in Hepatic Insulin Sensitivity after Roux-En-Y Gastric Bypass in a Rat Model of Obesity Is Partially Mediated via Hypo-thalamic Insulin Action. Diabetologia, 56, 2055-2058. [Google Scholar] [CrossRef] [PubMed]
[23] Cork, S.C. (2018) The Role of the Vagus Nerve in Appetite Control: Implications for the Pathogenesis of Obesity. Journal of Neu-roendocrinology, 30, e12643. [Google Scholar] [CrossRef] [PubMed]
[24] Alhabeeb, H., Alfaiz, A., Kutbi, E., et al. (2021) Gut Hormones in Health and Obesity: The Upcoming Role of Short Chain Fatty Acids. Nutrients, 13, Article 481. [Google Scholar] [CrossRef] [PubMed]
[25] Martinou, E., Stefanova, I., Iosif, E., et al. (2022) Neurohormonal Changes in the Gut-Brain Axis and Underlying Neuroendocrine Mechanisms Following Bariatric Surgery. International Journal of Molecular Sciences, 23, Article 3339. [Google Scholar] [CrossRef] [PubMed]
[26] Shapiro, H., Ko-lodziejczyk, A.A., Halstuch, D., et al. (2018) Bile Acids in Glucose Metabolism in Health and Disease. Journal of Ex-perimental Medicine, 215, 383-396. [Google Scholar] [CrossRef] [PubMed]
[27] Pathak, P., Xie, C., Nichols, R.G., et al. (2018) Intestine Farnesoid X Receptor Agonist and the Gut Microbiota Activate G-Protein Bile Acid Receptor-1 Signaling to Improve Metabolism. Hepatology, 68, 1574-1588. [Google Scholar] [CrossRef] [PubMed]
[28] Van Nierop, F.S., De Jonge, C., Kulik, W., et al. (2019) Duodenal-Jejunal Lining Increases Postprandial Unconjugated Bile Acid Responses and Disrupts the Bile Acid-FXR-FGF19 Axis in Hu-mans. Metabolism, 93, 25-32. [Google Scholar] [CrossRef] [PubMed]
[29] Betzel, B., Drenth, J.P.H. and Siersema, P.D. (2018) Adverse Events of the Duodenal-Jejunal Bypass Liner: A Systematic Review. Obesity Surgery, 28, 3669-3677. [Google Scholar] [CrossRef] [PubMed]
[30] De Moura, E.G., Martins, B.C., Lopes, G.S., et al. (2012) Meta-bolic Improvements in Obese Type 2 Diabetes Subjects Implanted for 1 Year with an Endoscopically Deployed Duode-nal-Jejunal Bypass Liner. Diabetes Technology & Therapeutics, 14, 183-189. [Google Scholar] [CrossRef] [PubMed]
[31] Quezada, N., Muñoz, R., Morelli, C., et al. (2018) Safety and Efficacy of the Endoscopic Duodenal-Jejunal Bypass Liner Prototype in Severe or Morbidly Obese Subjects Implanted for up to 3 Years. Surgical Endoscopy, 32, 260-267. [Google Scholar] [CrossRef] [PubMed]